Contact
searchSearch
HMP Global
Login

July/August 2025

Special Report
Navigating the Management of Metastatic Colorectal Cancer in the Advanced Treatment Setting: Insights From an Expert Panel
08/15/2025
Tanios Bekaii-Saab, MD, FACP; Stacey Cohen, MD; Marwan Fakih, MD; Anwaar Saeed, MD
Review a special report on the current treatment landscape and unmet needs in metastatic colorectal cancer (mCRC).
Review a special report on the current treatment landscape and unmet needs in metastatic colorectal cancer (mCRC).
Review a special report on the...
08/15/2025
Journal of Clinical Pathways
Research Reports
An Oncology Provider-Driven Model to Implement Germline Genetic Testing Among Diverse Patients With Advanced Prostate Cancer
08/15/2025
Lisa Nuccio, MSN, FNP-C; Kirsten Drabek, BS; Neha Hippalgaonkar, MD; Aseem Tiwari, MPH, MD, MBBS; Vivian Pan, MS, PhD; Kent Hoskins, MD; Pamela Ganschow, MD; Tara Maga, PhD, MS; Lara Balay, MS Ed, MS, CGC; Karine Tawagi, MD; Natalie Reizine, MD
In this study, researchers examine the clinical implementation of an oncology-directed model of delivering guideline-concordant germline genetic testing in patients living with and receiving standard-of-care treatment for advanced prostate...
In this study, researchers examine the clinical implementation of an oncology-directed model of delivering guideline-concordant germline genetic testing in patients living with and receiving standard-of-care treatment for advanced prostate...
In this study, researchers...
08/15/2025
Journal of Clinical Pathways
CPC+CBEx SESSION TEASERS
Integrating Comprehensive Care Needs into Clinical Pathways
08/15/2025
Barbara McAneny, MD
Drug prices are the focus of many people in health care, but no one is measuring the total cost of delivering the drugs to the patient. Getting a patient through chemotherapy requires attention to their side effects and toxicities, and their...
Drug prices are the focus of many people in health care, but no one is measuring the total cost of delivering the drugs to the patient. Getting a patient through chemotherapy requires attention to their side effects and toxicities, and their...
Drug prices are the focus of...
08/15/2025
Journal of Clinical Pathways
CPC+CBEx SESSION TEASERS
Predictable Cost of Care Working Group Phase 2 Update: Building the Model
08/15/2025
Carole Tremonti, RN, MBA
Decision support for oncology treatment has been at the forefront of oncology decision-making for over 20 years, yet the methods in which we evaluate and select regimens for a pathway has remained the same. Within our community, we have all...
Decision support for oncology treatment has been at the forefront of oncology decision-making for over 20 years, yet the methods in which we evaluate and select regimens for a pathway has remained the same. Within our community, we have all...
Decision support for oncology...
08/15/2025
Journal of Clinical Pathways
EDITORIAL BOARD TESTIMONIALS
The Power of Pathways: Editorial Board Perspectives From a Decade of JCP
08/15/2025
Alan J. Balch, PhD, MSc; Gordon Kuntz; Lalan Wilfong, MD; F. Randy Vogenberg, PhD, FASHP
Journal of Clinical Pathways board members share their perspectives on the lasting and emerging role of pathways as tools for evidence-based, high-value care and as frameworks that support clinicians, inform stakeholder decisions, and center...
Journal of Clinical Pathways board members share their perspectives on the lasting and emerging role of pathways as tools for evidence-based, high-value care and as frameworks that support clinicians, inform stakeholder decisions, and center...
Journal of Clinical Pathways...
08/15/2025
Journal of Clinical Pathways
CPC+CBEx SESSION TEASERS
Bridging the Care Gaps: Patient Support and Extended Cross-Continuum Care Management Outside the Clinic Walls
08/15/2025
Dan Nardi
Learn how a thoughtfully integrated combination of clinical teams and scalable, [artificial intelligence] technology can enable around-the-clock patient support, reinforce adherence to evidence-based clinical pathways, and extend high-quality...
Learn how a thoughtfully integrated combination of clinical teams and scalable, [artificial intelligence] technology can enable around-the-clock patient support, reinforce adherence to evidence-based clinical pathways, and extend high-quality...
Learn how a thoughtfully...
08/15/2025
Journal of Clinical Pathways
CPC+CBEx KEYNOTE SPEAKER
Unburdened and Empowered: Building the Future of Trust-Based, Frictionless Care
08/15/2025
Thomas Koulopoulos
This year’s keynote speaker for CPC + CBEx, Thomas Koulopoulos, chairman and founder of the Delphi Group, offers his insights on transforming health care into a “life system” powered by digital advocates, seamless experiences, and a renewed...
This year’s keynote speaker for CPC + CBEx, Thomas Koulopoulos, chairman and founder of the Delphi Group, offers his insights on transforming health care into a “life system” powered by digital advocates, seamless experiences, and a renewed...
This year’s keynote speaker for...
08/15/2025
Journal of Clinical Pathways
Special Report
Predictable Cost of Care Model for Treatment Decisions: Working Group Consensus Statements for Metastatic Non-Small Cell Lung Cancer
08/15/2025
Edward Arrowsmith, MD; Vishnukamal Golla, MD, MPH; Rhonda Henschel, MBA; Andrew Hertler, MD, FACP; David Jackman, MD; Gordon Kuntz; Olaf Lodbrok, MS, MBA; Carole Tremonti, RN, MBA; Lalan Wilfong, MD
The Predictable Cost of Care Working Group developed a model that can be used by various entities evaluating the impact of treatment on the total cost of care.
The Predictable Cost of Care Working Group developed a model that can be used by various entities evaluating the impact of treatment on the total cost of care.
The Predictable Cost of Care...
08/15/2025
Journal of Clinical Pathways
From the Field
Bridging the Gap Between Oncologists and Payers: Impact of an EHR-Embedded CDS Tool in Oncology Clinical Pathway (OCP) Adherence
08/15/2025
Anna Bolha, MPAS, PA; Rebecca Maniago, PharmD, BCOP; Nina Sardesh; Taylor Dias-Foundas; James Roose, MA; Colin Harvey; Marcello Ricottone; Eric Weber; Susan Sabo-Wagner, MSN, RN, OCN, NEA-BC; Brian Patrick Mulherin, MD; Andrew Hertler, MD, FACP; James Hamrick, MD, MPH
In this report, researchers discuss a real-world study of treatment selection patterns across American Oncology Network medical oncologists, which analyzed pathway adherence rates before and after a pilot project where Evolent level 1...
In this report, researchers discuss a real-world study of treatment selection patterns across American Oncology Network medical oncologists, which analyzed pathway adherence rates before and after a pilot project where Evolent level 1...
In this report, researchers...
08/15/2025
Journal of Clinical Pathways
Letter from the Editor
Converging Voices in Pathway Innovation: A Special CPC+CBEx Edition
08/15/2025
Winston Wong, PharmD
Celebrate a decade of innovation in value-based cancer care with the Journal of Clinical Pathways’ (JCP) special issue, spotlighting the synergy between JCP and the Clinical Pathways Congress + Cancer Care Business Exchange through...
Celebrate a decade of innovation in value-based cancer care with the Journal of Clinical Pathways’ (JCP) special issue, spotlighting the synergy between JCP and the Clinical Pathways Congress + Cancer Care Business Exchange through...
Celebrate a decade of innovation...
08/15/2025
Journal of Clinical Pathways
ONLINE EXCLUSIVES
Developing a National Pathway Framework for Prostate Cancer: Insights From Solaris Health
08/15/2025
Jason Hafron, MD
Jason Hafron, MD, discusses how Solaris Health developed and implemented standardized, National Comprehensive Cancer Network (NCCN)-based prostate cancer pathways across its national network to ensure consistent, high-quality care, streamline...
Jason Hafron, MD, discusses how Solaris Health developed and implemented standardized, National Comprehensive Cancer Network (NCCN)-based prostate cancer pathways across its national network to ensure consistent, high-quality care, streamline...
Jason Hafron, MD, discusses how...
08/15/2025
Journal of Clinical Pathways
Research Reports
Oncology Pathways Drive Adoption of High-Quality Treatment Regimens and Deliver Drug Cost Savings
08/15/2025
Kathryn Christensen, MD, MS; Timothy Dollear, MD, MS; Rama Al Ghannam, PharmD; Eric Gratias, MD, FAAP; Robinson Ortiz, MD; Stephen Hamilton, MD
Kathryn Christensen, MS, and colleagues share the initial results of the launch of Cigna and eviCore Healthcare’s Oncology Value-based Pathways program.
Kathryn Christensen, MS, and colleagues share the initial results of the launch of Cigna and eviCore Healthcare’s Oncology Value-based Pathways program.
Kathryn Christensen, MS, and...
08/15/2025
Journal of Clinical Pathways
From the Field
Operationalizing Weight-Based Dosing of Pembrolizumab: Opportunities and Challenges
08/15/2025
Samyukta Mullangi, MD, MBA; Alphan Kirayoglu, MA; Amila Patel, PharmD; Robert J. Green, MD, MSCE; Keshav Goel, MS; James Gilmore, PharmD; Stephen Garrel Divers, MD
To curb the high cost of cancer care driven by flat-dose pricing of drugs like pembrolizumab, the American Oncology Network has implemented a suite of technological and workflow innovations that increased weight-based dosing, offering a...
To curb the high cost of cancer care driven by flat-dose pricing of drugs like pembrolizumab, the American Oncology Network has implemented a suite of technological and workflow innovations that increased weight-based dosing, offering a...
To curb the high cost of cancer...
08/15/2025
Journal of Clinical Pathways
Review
Remote Therapeutic Monitoring to Support Adoption of Bispecific Antibody Therapy in Community Practices
08/15/2025
James H. Holmes, IV, MD, FACS; Benjamin A. Derman, MD; Barry Brooks, MD; Gurjyot K. Doshi, MD; Michael Kolodziej, MD; Lavi Kwiatkowsky; Geoffrey Calkins; Mustafa S. Ascha, PhD, MS
This review explores the clinical potential of bispecific antibodies (BsAbs), the barriers to their adoption in community clinics, and how remote therapeutic monitoring (RTM) can streamline patient management to enhance outcomes and reduce...
This review explores the clinical potential of bispecific antibodies (BsAbs), the barriers to their adoption in community clinics, and how remote therapeutic monitoring (RTM) can streamline patient management to enhance outcomes and reduce...
This review explores the...
08/15/2025
Journal of Clinical Pathways
JCP Nov-Dec Cover

Current Issue

December 2025
Volume 11
Issue 6
Current Issue
Issue Archive

Special Reports

Special Report
Navigating the Management of Metastatic Colorectal Cancer in the Advanced Treatment Setting: Insights From an Expert Panel
08/15/2025
Tanios Bekaii-Saab, MD, FACP; Stacey Cohen, MD; Marwan Fakih, MD; Anwaar Saeed, MD
Review a special report on the current treatment landscape and unmet needs in metastatic colorectal cancer (mCRC).
Review a special report on the current treatment landscape and unmet needs in metastatic colorectal cancer (mCRC).
Review a special report on the...
08/15/2025
Journal of Clinical Pathways
Special Report
Predictable Cost of Care Model for Treatment Decisions: Working Group Consensus Statements for Metastatic Non-Small Cell Lung Cancer
08/15/2025
Edward Arrowsmith, MD; Vishnukamal Golla, MD, MPH; Rhonda Henschel, MBA; Andrew Hertler, MD, FACP; David Jackman, MD; Gordon Kuntz; Olaf Lodbrok, MS, MBA; Carole Tremonti, RN, MBA; Lalan Wilfong, MD
The Predictable Cost of Care Working Group developed a model that can be used by various entities evaluating the impact of treatment on the total cost of care.
The Predictable Cost of Care Working Group developed a model that can be used by various entities evaluating the impact of treatment on the total cost of care.
The Predictable Cost of Care...
08/15/2025
Journal of Clinical Pathways
Special Report
Navigating the Management of Metastatic Colorectal Cancer in the Advanced Treatment Setting: Insights From an Expert Panel
06/12/2025
Tanios Bekaii-Saab, MD, FACP; Stacey Cohen, MD; Marwan Fakih, MD; Anwaar Saeed, MD
Review a special report on the current treatment landscape and unmet needs in metastatic colorectal cancer (mCRC).
Review a special report on the current treatment landscape and unmet needs in metastatic colorectal cancer (mCRC).
Review a special report on the...
06/12/2025
Journal of Clinical Pathways
Page 1
Special Report
Predictable Cost of Care Model for Treatment Decisions: Working Group Consensus Statements for Metastatic Non-Small Cell Lung Cancer
02/19/2025
Edward Arrowsmith, MD; Vishnukamal Golla, MD, MPH; Rhonda Henschel, MBA; Andrew Hertler, MD, FACP; David Jackman, MD; Gordon Kuntz; Olaf Lodbrok, MS, MBA; Carole Tremonti, RN, MBA; Lalan Wilfong, MD
The Predictable Cost of Care Working Group developed a model that can be used by various entities evaluating the impact of treatment on the total cost of care.
The Predictable Cost of Care Working Group developed a model that can be used by various entities evaluating the impact of treatment on the total cost of care.
The Predictable Cost of Care...
02/19/2025
Journal of Clinical Pathways
JCP Special Report
Recommendations for Creating an Oncology Clinical Pathways Framework Tool Based on Payer, Provider, and Patient Priorities: Findings From the 2021 Care Pathways Working Group
05/20/2022
Robin T. Zon, MD, FACP, FASCO; Gordon Kuntz; Winston Wong, PharmD
The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...
The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...
The Journal of Clinical Pathways...
05/20/2022
Journal of Clinical Pathways

August 2025 Volume 11 Issue 4

View Issue Archive
Editorial Correspondence

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use